Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Beller

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Obstetrics and Gynecology|January 1, 1989
The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative managementS R Goldstein, B Subramanyam, J R Snyder, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 1, 1995
The effect of feedback on anxiety levels during ultrasound scanning for ovarian cancerO P Tadmor, Z Zlotogorski, M Galron-Duniec, et al.
Radiology|February 1, 1988
Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomyA J Megibow, M A Bosniak, A G Ho, et al.
Gynecologic Oncology|September 1, 1989
Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary reportU Beller, A Chachoua, J L Speyer, et al.
Cancer|January 1, 1990
The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovaryR J Brescia, R A Barakat, U Beller, et al.
Investigational New Drugs|August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancerM D Green, J L Speyer, J C Wernz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancerU Beller, J Speyer, N Colombo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinantM J Dattoli, H F Gretz, U Beller, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Advanced ovarian cancer: three-year results of a 6-8 month, 2-drug cisplatin-containing regimenM J Piccart, J L Speyer, J C Wernz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patientsN Colombo, J L Speyer, M Green, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Obstetrics and Gynecology|January 1, 1989
The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative managementS R Goldstein, B Subramanyam, J R Snyder, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 1, 1995
The effect of feedback on anxiety levels during ultrasound scanning for ovarian cancerO P Tadmor, Z Zlotogorski, M Galron-Duniec, et al.
Radiology|February 1, 1988
Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomyA J Megibow, M A Bosniak, A G Ho, et al.
Gynecologic Oncology|September 1, 1989
Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary reportU Beller, A Chachoua, J L Speyer, et al.
Cancer|January 1, 1990
The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovaryR J Brescia, R A Barakat, U Beller, et al.
Investigational New Drugs|August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancerM D Green, J L Speyer, J C Wernz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancerU Beller, J Speyer, N Colombo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinantM J Dattoli, H F Gretz, U Beller, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Advanced ovarian cancer: three-year results of a 6-8 month, 2-drug cisplatin-containing regimenM J Piccart, J L Speyer, J C Wernz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patientsN Colombo, J L Speyer, M Green, et al.
Pageof 7